These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32272938)

  • 1. Trehalose alleviates the phenotype of Machado-Joseph disease mouse models.
    Santana MM; Paixão S; Cunha-Santos J; Silva TP; Trevino-Garcia A; Gaspar LS; Nóbrega C; Nobre RJ; Cavadas C; Greif H; Pereira de Almeida L
    J Transl Med; 2020 Apr; 18(1):161. PubMed ID: 32272938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.
    Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP
    PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.
    Nascimento-Ferreira I; Nóbrega C; Vasconcelos-Ferreira A; Onofre I; Albuquerque D; Aveleira C; Hirai H; Déglon N; Pereira de Almeida L
    Brain; 2013 Jul; 136(Pt 7):2173-88. PubMed ID: 23801739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease.
    Duarte-Neves J; Gonçalves N; Cunha-Santos J; Simões AT; den Dunnen WF; Hirai H; Kügler S; Cavadas C; Pereira de Almeida L
    Hum Mol Genet; 2015 Oct; 24(19):5451-63. PubMed ID: 26220979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine alleviates progressive motor deficits in a transgenic mouse model of spinocerebellar ataxia.
    Gonçalves N; Simões AT; Prediger RD; Hirai H; Cunha RA; Pereira de Almeida L
    Ann Neurol; 2017 Mar; 81(3):407-418. PubMed ID: 28032667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y (NPY) intranasal delivery alleviates Machado-Joseph disease.
    Duarte-Neves J; Cavadas C; Pereira de Almeida L
    Sci Rep; 2021 Feb; 11(1):3345. PubMed ID: 33558582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.
    Watchon M; Yuan KC; Mackovski N; Svahn AJ; Cole NJ; Goldsbury C; Rinkwitz S; Becker TS; Nicholson GA; Laird AS
    J Neurosci; 2017 Aug; 37(32):7782-7794. PubMed ID: 28687604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.
    Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Conceição M; Déglon N; de Almeida LP
    Cerebellum; 2013 Aug; 12(4):441-55. PubMed ID: 23242710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease.
    Vasconcelos-Ferreira A; Carmo-Silva S; Codêsso JM; Silva P; Martinez ARM; França MC; Nóbrega C; Pereira de Almeida L
    Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12763. PubMed ID: 34432315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3.
    Nóbrega C; Codêsso JM; Mendonça L; Pereira de Almeida L
    Hum Gene Ther; 2019 Jul; 30(7):841-854. PubMed ID: 30760052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
    Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP
    Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered glucose metabolism and its association with carbonic anhydrase 8 in Machado-Joseph Disease.
    Lin GY; Ma CY; Kuo LC; Hsieh BY; Wang H; Liu CS; Hsieh M
    Metab Brain Dis; 2022 Aug; 37(6):2103-2120. PubMed ID: 35488942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples.
    Duarte Lobo D; Nobre RJ; Oliveira Miranda C; Pereira D; Castelhano J; Sereno J; Koeppen A; Castelo-Branco M; Pereira de Almeida L
    Acta Neuropathol Commun; 2020 Aug; 8(1):152. PubMed ID: 32867861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease.
    Simões AT; Gonçalves N; Nobre RJ; Duarte CB; Pereira de Almeida L
    Hum Mol Genet; 2014 Sep; 23(18):4932-44. PubMed ID: 24817574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machado Joseph disease severity is linked with gut microbiota alterations in transgenic mice.
    Gamage HKAH; Robinson KJ; Luu L; Paulsen IT; Laird AS
    Neurobiol Dis; 2023 Apr; 179():106051. PubMed ID: 36822548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the calpain-generated toxic fragment of ataxin-3 protein provides new avenues for therapy of Machado-Joseph disease| Spinocerebellar ataxia type 3.
    Simões AT; Carmona V; Duarte-Neves J; Cunha-Santos J; Pereira de Almeida L
    Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12748. PubMed ID: 34273111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia.
    Nóbrega C; Mendonça L; Marcelo A; Lamazière A; Tomé S; Despres G; Matos CA; Mechmet F; Langui D; den Dunnen W; de Almeida LP; Cartier N; Alves S
    Acta Neuropathol; 2019 Nov; 138(5):837-858. PubMed ID: 31197505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease.
    Nascimento-Ferreira I; Santos-Ferreira T; Sousa-Ferreira L; Auregan G; Onofre I; Alves S; Dufour N; Colomer Gould VF; Koeppen A; Déglon N; Pereira de Almeida L
    Brain; 2011 May; 134(Pt 5):1400-15. PubMed ID: 21478185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias.
    Colomer Gould VF
    NeuroRx; 2005 Jul; 2(3):480-3. PubMed ID: 16389311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease.
    Silva-Fernandes A; Duarte-Silva S; Neves-Carvalho A; Amorim M; Soares-Cunha C; Oliveira P; Thirstrup K; Teixeira-Castro A; Maciel P
    Neurotherapeutics; 2014 Apr; 11(2):433-49. PubMed ID: 24477711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.